Pure Global
NCT06420661

School Partnered Collaborative Care (SPACE) Intervention for Children With Type 1 Diabetes

School Partnered Collaborative Care (SPACE) for Pediatric Type 1 Diabetes: A Pilot Feasibility Trial
University of Pittsburgh·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Type 1 Diabetes
Drug/Device/Intervention
SPACE for T1D
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of Pittsburgh
Location
Pittsburgh, United States of America
Timeline & enrollment
Phase
N/A
Start date
Aug 01, 2024
End date
Apr 30, 2027
Enrollment
30 participants
Primary outcome

Feasibility of Intervention Measure (FIM)

Summary

This is a pilot trial of a school-partnered collaborative care (SPACE) model for pediatric
 type 1 diabetes. The trial will investigate the feasibility and acceptability of SPACE for
 children with type 1 diabetes in the school setting. SPACE is adapted from a collaborative
 care model used to treat depression and other mental health care conditions in adolescents
 and adults.

ICD-10 classifications
Type 1 diabetes mellitusType 1 diabetes mellitus without complicationsType 1 diabetes mellitus with unspecified complicationsType 1 diabetes mellitus with other specified complicationsType 1 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06420661
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06420661 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Pittsburgh and is currently Not yet recruiting. The study focuses on Type 1 Diabetes. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.